A3951012
Erythromycin , Efficiency ≥850 μg/mg , 114-07-8
Synonym(s):
Erythromycin;USP;Erythromycin A;Erythromycinum;Volumetric flasks
CAS NO.:114-07-8
Empirical Formula: C37H67NO13
Molecular Weight: 733.93
MDL number: MFCD00084654
EINECS: 204-040-1
Pack Size | Price | Stock | Quantity |
1g | RMB24.00 | In Stock |
|
5G | RMB41.60 | In Stock |
|
25G | RMB129.60 | In Stock |
|
100G | RMB503.20 | In Stock |
|
500g | RMB1864.00 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 133 °C |
alpha | -74.5 º (c=2, ethanol) |
Boiling point: | 719.69°C (rough estimate) |
Density | 1.1436 (rough estimate) |
refractive index | -74 ° (C=2, EtOH) |
storage temp. | Inert atmosphere,Room Temperature |
solubility | ethanol: soluble |
form | powder |
pka | 8.8(at 25℃) |
color | white to faint yellow |
optical activity | [α]/D -78 to --71° |
Water Solubility | Soluble in water at 2mg/ml |
Merck | 14,3681 |
BRN | 8183758 |
InChIKey | HIYRERIGRWIODP-PNFGZDISSA-N |
EPA Substance Registry System | Erythromycin (114-07-8) |
Description and Uses
Erythromycin ethyl succinate is a mixed double ester pro-drug in which one carboxyl of succinic acid esterifies the C-2′ hydroxyl of erythromycin and the other ethanol. This pro-drug frequently is used in an oral suspension for pediatric use largely to mask the bitter taste of the drug. Film-coated tablets also are used to deal with this. Some cholestatic jaundice is associated with the use of EES.
Macrolide antibacterial
Safety
Symbol(GHS) | GHS02,GHS08 |
Signal word | Warning |
Hazard statements | H225-H333-H371 |
Precautionary statements | P210-P260-P280a-P303+P361+P353-P405-P501a |
Hazard Codes | Xn,Xi |
Risk Statements | 42/43-36/37/38 |
Safety Statements | 45-37-24-36-26-24/25 |
WGK Germany | 2 |
RTECS | KF4375000 |
F | 3-4.3-10 |
HazardClass | 3 |
HS Code | 29415000 |
Hazardous Substances Data | 114-07-8(Hazardous Substances Data) |
Toxicity | LD50 oral in rat: 4600mg/kg |